Bringing Sickle Cell Screening
to Every Newborn

MedInno supports large-scale sickle cell screening with diagnostic solutions designed to bring reliable testing closer to communities across India, including underserved and hard-to-reach regions.

Partner With Us
OVERVIEW

Sickle Cell Disease Remains Widely Undiagnosed

Most children born with sickle cell disease in low-resource settings are never screened at birth, losing the early window when preventive care saves lives.

515K

New Births With SCD

7.7M+

People Living With SCD

90%

Of Cases In LMICs

THE MEDINNO APPROACH

A scalable workflow designed to reduce the cost of population-wide testing

SCREENING WORKFLOW

Geographic Mapping

We map districts with high carrier-trait prevalence, directing screening resources to the birthing centres and communities at greatest risk.

SCREENING WORKFLOW

Community Mobilization

Community health workers and ASHA networks counsel expecting families and register newborns for point-of-care screening.

SCREENING WORKFLOW

Sample Collection

A single heel-prick blood sample is collected at birth using simple, low-infrastructure protocols suited to rural facilities.

SCREENING WORKFLOW

Rapid Molecular Testing

Samples are processed using the appropriate screening and analytical methods to identify individuals who may have the sickle cell trait or disease and require further evaluation.

SCREENING WORKFLOW

Treatment Linkage & Reporting

Positive cases are logged on our digital dashboard and linked directly to paediatric haematology clinics for early care.

Technology

Screening Technology Beyond Labs

MedInno's diagnostic platforms are engineered for heat, dust, and unreliable power, so accurate sickle cell screening works as well in a village clinic as in a city hospital.

Nucleic Acid Extraction

Our low-cost extraction kits isolate DNA from a single blood spot without cold storage or specialised lab technicians.

Targeted Real-Time PCR

Purpose-built assays distinguish sickle trait from sickle cell disease in one run, avoiding the delays of centralised reference labs.

Field-Ready Infrastructure

Battery-powered analysers and rugged carry cases keep newborn screening operational through power cuts and long field deployments.

Impact On Systems

Greater Rural Reach

Decentralised screening brings sickle cell testing to sub-district birthing centres, closing the gap for families far from tertiary hospitals.

Impact On Systems

Faster Case Notification

Diagnosis within days of birth lets families start penicillin prophylaxis and vaccination before complications begin.

Impact On Systems

Reduced Loss to Follow-Up

Early identification and simple preventive care can meaningfully lower the disproportionate under-five mortality linked to undiagnosed sickle cell disease.

FOR LOW-RESOURCE SETTINGS

Designed for gaps in standard diagnostic systems.

Metropolitan labs assume constant electricity, sterile clinical counters, and advanced laboratory engineers. Remote blocks present real structural barriers: spotty power, extreme heat, unpaved terrain, and diagnostic resource shortages.

MedInno systematically optimizes molecular reagents to maintain thermal tolerance, packages workflows inside portable rugged travel cases, and optimizes software for offline-sync data logging.
Collaboration

Mass screening is most effective as a public-health effort.

Government Health Departments Public Health & Multilateral Bodies NGOs & Global Health Foundations CSR & Corporate Partners
icon

Government Health Departments

State health missions rely on MedInno to extend newborn screening beyond district hospitals into block-level birthing centres, supporting national sickle cell elimination targets without new permanent lab infrastructure.

icon

Public Health & Multilateral Bodies

Public health bodies use MedInno's field data to track screening coverage and direct funding toward the regions with the highest carrier-trait prevalence.

icon

NGOs & Global Health Foundations

NGOs running maternal and child health drives pair our portable kits with community health workers, reaching tribal belts and remote birthing centres that hospital labs rarely cover.

icon

CSR & Corporate Partners

Corporate CSR programmes fund newborn screening camps in high-prevalence districts, combining compliance with measurable early-childhood health impact.

Partner With Us to Expand Sickle Cell Screening


MedInno works with governments, NGOs and healthcare institutions to strengthen screening programmes and bring reliable diagnostic access closer to communities affected by sickle cell disease.

Get In Touch